The main reasons for referral to CRAM were that the patients were in advanced clinical stages (WHO stages 3 or 4, or less than 50 CD4 cells/μl) in 70% (1,158) of the cases, and 19% (314) had Kaposi sarcoma. The gene discussed is CD4; the disease is Kaposi's sarcoma.